CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

No trades
See on Supercharts

600062 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the processing, manufacture, and sale of pharmaceutical, chemical, and biomedical raw materials. It operates through the following business segments: Infusion and Non-infusion. Its products include compound reserpine flattamine tablets, amlodipine besylate tablets, gliquidone tablets, citicoline sodium tablets, magnesium valproate sustained-release tablets, and soft bags. The company was founded on May 16, 1997 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

600062 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company